Uniform mesoporous CaSiO 3 :Eu 3+ nanospheres: Template-directed synthesis, luminescence and sustained drug release properties
Source abstract
Abstract
Abstract Mesoporous calcium silicate has emerged as appealing hosts for the exploitation of novel nanocarriers featuring “on demand” drug delivery. The uniform and well-dispersed Eu3+-doped calcium silicate nanospheres have been prepared with monodisperse mesoporous silica nanospheres as template. The as-obtained spherical composite may be potentially applied as a drug carrier due to their advantages such as high biocompatibility, proper particle size (100 nm), large specific surface area, nanosized channels for drug loading and release, superior drug loading capacity and longer efficiency time of the drug release behavior. In particular, the composite exhibits intense red emission at 612 nm. After loading the model drug, the emission intensity decreases evidently. The luminescence intensity change may be potentially applied to monitor or track the drug release process. The mesoporous, biocompatible, and luminescent drug delivery system may find potential applications in fields of controlled drug delivery, cell imaging, and disease diagnosis.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Luminescence Properties of Advanced Materials · Chemical Synthesis and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Third-generation biomedical materials10.1126/science.1067404 ↗
2. Mesoporous silica nanoparticles for drug delivery and biosensing applications10.1002/adfm.200601191 ↗
3. Mesoporous silica films with accessible pore structures on iron oxide10.1016/j.dyepig.2015.08.025 ↗
4. Controlling physical features of mesoporous silica nanoparticles (MSNs) for emerging applications10.1039/C1JM13811A ↗
5. New trend on mesoporous films: precise controls of one-dimensional (1D) mesochannels toward innovative applications10.1039/c1jm10548e ↗
6. Nanoarchitectures for mesoporous metals10.1002/adma.201502593 ↗
7. Multifunctional nanoparticles for multimodal imaging and theragnosis10.1039/C2CS15261D ↗
8. Facile fabrication of hollow mesoporous Eu3+-doped Gd2O3 nanoparticles for dual-modal imaging and drug delivery10.1016/j.dyepig.2015.07.015 ↗
9. Multifunctional hybrid nanocarrier: magnetic CNTs ensheathed with mesoporous silica for drug delivery and imaging system10.1021/am4056936 ↗
10. pH-tunable calcium phosphate covered mesoporous silica nanocontainers for intracellular controlled release of guest drugs10.1002/anie.201101536 ↗
11. Water-soluble hypocrellin A nanoparticles as a photodynamic therapy delivery system10.1016/j.dyepig.2008.11.009 ↗
12. Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier10.1016/j.biomaterials.2008.07.042 ↗
13. Soluble cyanine dye/β-cyclodextrin derivatives: potential carriers for drug delivery and optical imaging10.1016/j.dyepig.2014.11.014 ↗
14. Preparation, characterization, and in vitro phototoxic effect of zinc phthalocyanine cucurbit[7]uril complex encapsulated into liposomes10.1016/j.dyepig.2013.08.018 ↗
15. Bone cement based on vancomycin loaded mesoporous silica nanoparticle and calcium sulfate composites10.1016/j.msec.2014.12.082 ↗
16. Magnetic and luminescent Fe3O4/Y2O3:Eu3+ composites with hollow spheres and mesoporous silica10.1016/j.dyepig.2014.01.028 ↗
17. Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core–shell structure10.1002/anie.200501500 ↗
18. Effects of altering the Si/Ca molar ratio of a calcium silicate cement on in vitro cell attachment10.1111/j.1365-2591.2011.01981.x ↗
19. Preparation, mechanical property and cytocompatibility of poly (l-lactic acid)/calcium silicate nanocomposites with controllable distribution of calcium silicate nanowires10.1016/j.actbio.2012.07.009 ↗
20. Preparation and characterization of bioactive mesoporous wollastonite-polycaprolactone composite scaffold10.1016/j.biomaterials.2008.10.046 ↗
21. Fabrication and characterization of hydroxyapatite/wollastonite composite bioceramics with controllable properties for hard tissue repair10.1111/j.1551-2916.2010.04046.x ↗
22. The in-vitro bioactivity of mesoporous bioactive glasses10.1016/j.biomaterials.2006.01.043 ↗
23. Substitutions of strontium in mesoporous calcium silicate and their physicochemical and biological properties10.1016/j.actbio.2013.01.021 ↗
24. The influences of poly(lactic-co-glycolic acid) (PLGA) coating on the biodegradability, bioactivity, and biocompatibility of calcium silicate bioceramics10.1007/s10853-011-5416-9 ↗
25. Preparation and characterization of mesoporous calcium silicate grafted polypropylene non-woven fabric10.1016/j.matlet.2014.11.055 ↗
26. A template route to the preparation of mesoporous amorphous calcium silicate with high in vitro bone-forming bioactivity10.1002/jbm.b.30813 ↗
27. Facile large-scale synthesis of monodisperse mesoporous silica nanospheres with tunable pore structure10.1021/ja3116873 ↗
28. Diamine functionalized cubic mesoporous silica for ibuprofen controlled delivery10.1166/jnn.2015.9811 ↗
29. Can bioactivity be tested in vitro with SBF solution?10.1016/j.biomaterials.2009.01.008 ↗
30. Defect-related luminescent mesoporous silica nanoparticles employed for novel detectable nanocarrier10.1021/acsami.5b02146 ↗